Triple agonist: difference between revisions
Diff·revision 9 → 10·17:57, 28 Jan 2025
Difference between revision 9 and revision 10 of Triple agonist. 1 line changed; the page grew by 27 bytes.
| Revision 9 — 17:26, 5 Jan 2025 SchematicScout (talk) the lead claimed weekly dosing for a compound dosed daily; corrected 3,120 bytes +574 | Revision 10 — 17:57, 28 Jan 2025 GMP_Gita (talk) convert the substitution list to a table so the analogues line up 3,147 bytes +27 | ||
|---|---|---|---|
| 1 | {{Infobox concept | 1 | {{Infobox concept |
| 2 | | name = Triple agonist | 2 | | name = Triple agonist |
| + | 3 | | subtitle = Drug class | |
| 3 | | Usual receptors = GIP, [[GLP-1 receptor|GLP-1]] and [[Glucagon|glucagon]] | 4 | | Usual receptors = GIP, [[GLP-1 receptor|GLP-1]] and [[Glucagon|glucagon]] |
| 4 | | Leading example = [[Retatrutide]] | 5 | | Leading example = [[Retatrutide]] |